Skip to main content

Peer Review reports

From: Favorable response to doxorubicin combination chemotherapy does not yield good clinical outcome in patients with metastatic breast cancer with triple-negative phenotype

Original Submission
1 Oct 2009 Submitted Original manuscript
25 Nov 2009 Reviewed Reviewer Report - William Irvin
26 Nov 2009 Reviewed Reviewer Report - Reiki Nishimura
1 Dec 2009 Reviewed Reviewer Report - Jun Jiang
19 Jan 2010 Author responded Author comments - Jin Seok Ahn
Resubmission - Version 2
19 Jan 2010 Submitted Manuscript version 2
20 Jan 2010 Reviewed Reviewer Report - Reiki Nishimura
2 Feb 2010 Reviewed Reviewer Report - William Irvin
23 Feb 2010 Reviewed Reviewer Report - Jun Jiang
30 Jun 2010 Reviewed Reviewer Report - Freedom Nkhululeko Gumedze
25 Jul 2010 Author responded Author comments - Jin Seok Ahn
Resubmission - Version 3
25 Jul 2010 Submitted Manuscript version 3
10 Aug 2010 Reviewed Reviewer Report - William Irvin
23 Aug 2010 Author responded Author comments - Jin Seok Ahn
Resubmission - Version 4
23 Aug 2010 Submitted Manuscript version 4
30 Sep 2010 Author responded Author comments - Jin Seok Ahn
Resubmission - Version 5
30 Sep 2010 Submitted Manuscript version 5
Publishing
5 Oct 2010 Editorially accepted
5 Oct 2010 Article published 10.1186/1471-2407-10-527

You can find further information about peer review here.

Back to article page